HomeSOPH • NASDAQ
Sophia Genetics SA
$5.17
Mar 28, 2:01:31 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$5.26
Day range
$4.95 - $5.21
Year range
$2.13 - $7.37
Market cap
337.61M USD
Avg Volume
64.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
17.05M27.38%
Operating expense
30.82M25.07%
Net income
-24.06M-72.22%
Net profit margin
-141.14-35.20%
Earnings per share
-0.28-66.71%
EBITDA
-18.45M-25.63%
Effective tax rate
-0.03%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
123.25M-31.00%
Total assets
206.16M-15.45%
Total liabilities
54.71M25.18%
Total equity
151.44M
Shares outstanding
65.30M
Price to book
2.27
Return on assets
-22.96%
Return on capital
-27.31%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-24.06M-72.22%
Cash from operations
-11.29M-9.32%
Cash from investing
-2.25M-118.53%
Cash from financing
-506.00K12.76%
Net change in cash
-9.52M-373.61%
Free cash flow
-6.03M32.56%
About
Sophia Genetics is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B. Wikipedia
Founded
Jan 1, 2011
Employees
430
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu